Literature DB >> 21880858

Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset.

Harry E Prince1, Cindy Yeh, Mary Lapé-Nixon.   

Abstract

Dengue virus (DV) IgM/IgG ratio and IgG avidity value (AV) can reliably distinguish between primary and secondary DV infections using sera collected within 30 days of disease onset, but little is known about their efficacies using sera collected >30 days after onset. To investigate this issue, we analyzed specimens submitted to our reference laboratory for DV antibody testing. We first classified patients as having primary (n = 55) or secondary (n = 58) infections based on seroconversion patterns in a comparison of two sera collected <30 days apart. We then evaluated IgM/IgG ratios and IgG AVs of the second specimens by using receiver operating characteristic curve analysis. The IgM/IgG ratio that best discriminated primary from secondary infection was 1.32; 95% of 55 primary infections exhibited ratios of >1.32, whereas 93% of 58 secondary infections exhibited ratios of ≤1.32. The discriminatory AV was 0.39; 95% of 41 primary infections exhibited AVs of ≤0.39, whereas 95% of 38 secondary infections exhibited AVs of >0.39. We then evaluated the IgM/IgG ratios and AV for primary-infection patients whose second serum samples were collected ≥30 days after the first serum samples; only 56% of 27 sera exhibited ratios of >1.32, whereas 81% of 21 sera exhibited AVs of ≤0.39. Assuming that the first specimens were collected within a week after symptoms appeared, these findings indicate that IgG AV is superior to the IgM/IgG ratio for distinguishing primary from secondary DV infections when using samples collected more than 5 weeks after disease onset.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880858      PMCID: PMC3209020          DOI: 10.1128/CVI.05278-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  26 in total

1.  Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections.

Authors:  Pei-Yun Shu; Li-Kuang Chen; Shu-Fen Chang; Yi-Yun Yueh; Ling Chow; Li-Jung Chien; Chuan Chin; Ting-Hsiang Lin; Jyh-Hsiung Huang
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections.

Authors:  Vanda Akico Ueda Fick de Souza; Silvana Fernandes; Evaldo Stanislau Araújo; Adriana Fumie Tateno; Olímpia M N P F Oliveira; Renato Reis Oliveira; Cláudio Sérgio Pannuti
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

3.  An ELISA procedure for the diagnosis of dengue infections.

Authors:  G Kuno; I Gómez; D J Gubler
Journal:  J Virol Methods       Date:  1991-06       Impact factor: 2.014

4.  Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections.

Authors:  Sophie Alcon; Antoine Talarmin; Monique Debruyne; Andrew Falconar; Vincent Deubel; Marie Flamand
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection.

Authors:  P Koraka; C Suharti; T E Setiati; A T Mairuhu; E Van Gorp; C E Hack; M Juffrie; J Sutaryo; G M Van Der Meer; J Groen; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies.

Authors:  J Groen; P Koraka; J Velzing; C Copra; A D Osterhaus
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

7.  An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate.

Authors:  B L Innis; A Nisalak; S Nimmannitya; S Kusalerdchariya; V Chongswasdi; S Suntayakorn; P Puttisri; C H Hoke
Journal:  Am J Trop Med Hyg       Date:  1989-04       Impact factor: 2.345

8.  Laboratory diagnosis of primary and secondary dengue infection.

Authors:  Stefan Schilling; Diana Ludolfs; Le Van An; Herbert Schmitz
Journal:  J Clin Virol       Date:  2004-11       Impact factor: 3.168

9.  Molecular and serologic markers of acute dengue infection in naive and flavivirus-vaccinated travelers.

Authors:  Cristina Domingo; Fernando de Ory; Juan Carlos Sanz; Noelia Reyes; Joaquim Gascón; Ole Wichmann; Sabino Puente; Mirjam Schunk; Rogelio López-Vélez; Joaquim Ruiz; Antonio Tenorio
Journal:  Diagn Microbiol Infect Dis       Date:  2009-09       Impact factor: 2.803

Review 10.  Dengue: the risk to developed and developing countries.

Authors:  T P Monath
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

View more
  16 in total

1.  Estimation of dengue virus IgM persistence using regression analysis.

Authors:  Harry E Prince; Jose L Matud
Journal:  Clin Vaccine Immunol       Date:  2011-10-26

2.  Primary and probable secondary dengue virus (DV) infection rates in relation to age among DV IgM-positive patients residing in the United States mainland versus the Caribbean islands.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

3.  The Limitation of Rapid Tests for DENV2 Infection in Host with Unique Immune Status: Low NS1 Antigenemia and Deficient Antibody Responses.

Authors:  Lei Yu; Yingfen Wen; Mengrong Xiang; Wenxin Hong; Lingzhai Zhao; Fuchun Zhang
Journal:  Virol Sin       Date:  2020-01-14       Impact factor: 4.327

4.  Unusual patterns of IgG avidity in some young children following two doses of the adjuvanted pandemic H1N1 (2009) influenza virus vaccine.

Authors:  Karen K Yam; Jyotsana Gupta; Angela Brewer; David W Scheifele; Scott Halperin; Brian J Ward
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

5.  Immunoglobulin G (IgG) to IgM ratio in secondary adult dengue infection using samples from early days of symptoms onset.

Authors:  Nata Pratama Hardjo Lugito; Andree Kurniawan
Journal:  BMC Infect Dis       Date:  2015-07-21       Impact factor: 3.090

6.  The Use of NS1 Rapid Diagnostic Test and qRT-PCR to Complement IgM ELISA for Improved Dengue Diagnosis from Single Specimen.

Authors:  Boon-Teong Teoh; Sing-Sin Sam; Kim-Kee Tan; Jefree Johari; Juraina Abd-Jamil; Poh-Sim Hooi; Sazaly AbuBakar
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

7.  Differentiating secondary from primary dengue using IgG to IgM ratio in early dengue: an observational hospital based clinico-serological study from North India.

Authors:  Khalid Hamid Changal; Ab Hameed Raina; Adnan Raina; Manzoor Raina; Rehana Bashir; Muzamil Latief; Tanveer Mir; Qayum Hamid Changal
Journal:  BMC Infect Dis       Date:  2016-11-28       Impact factor: 3.090

8.  Immunologic hypo- or non-responder in natural dengue virus infection.

Authors:  Guey Chuen Perng; Kulkanya Chokephaibulkit
Journal:  J Biomed Sci       Date:  2013-05-31       Impact factor: 8.410

Review 9.  Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome.

Authors:  Jih-Jin Tsai; Kulkanya Chokephaibulkit; Po-Chih Chen; Li-Teh Liu; Hui-Mien Hsiao; Yu-Chih Lo; Guey Chuen Perng
Journal:  J Biomed Sci       Date:  2013-12-05       Impact factor: 8.410

Review 10.  Diagnosis of Dengue Infection Using Conventional and Biosensor Based Techniques.

Authors:  Om Parkash; Rafidah Hanim Shueb
Journal:  Viruses       Date:  2015-10-19       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.